Search Results - "Alkasab, Mohammed Saad"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    TCTAP A-113 Improvement of Left Ventricular Dysfunction in Ischemic and Non-ischemic Groups Using Angiotensin Neprilysin Inhibitor - Prospective Observational Study

    TCTAP A-113 Improvement of Left Ventricular Dysfunction in Ischemic and Non-ischemic Groups Using Angiotensin Neprilysin Inhibitor - Prospective Observational Study by Alkasab, Saad, Alkasab, Mohammed Saad

    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Rivaroxaban Experience at Tertiary Care Centre in Saudi Arabia:A Retrospective Observational Study

    Rivaroxaban Experience at Tertiary Care Centre in Saudi Arabia:A Retrospective Observational Study by Riazuddin, Muhammad, Mpharm, Mohamed Ahmed, Butt, Muhammad Imran, Abufarhaneh, Mohammed, Masud Khan, Shahid, Emadi, Omar, AlKasab, Mohammed Saad, Fahad Alsudairy, Haifa, AlShammari, Khalid, Sheikh, Aamir, AlRashed, Abdulaziz

    Published in Galen (01-01-2020)
    “…Atrial fibrillation (AF) and Venous Thromboembolism (VTE) are significant causes of morbidity and mortality. Direct oral anticoagulants (DOACs) are as…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    AS-265: Incidence After the Use of Clopidogrel 150 mg + Aspirin 81 mg in Group 1 Versus Clopidogrel 75 mg + Aspirin 81 mg in Group 2 After Drug-Eluting Stenting for 1 Month in High-Risk Patients

    AS-265: Incidence After the Use of Clopidogrel 150 mg + Aspirin 81 mg in Group 1 Versus Clopidogrel 75 mg + Aspirin 81 mg in Group 2 After Drug-Eluting Stenting for 1 Month in High-Risk Patients by Alkasab, Saad Mohammed, Alanazi, Menwar M, Alshehri, Mohammad, Nourallah, Rida, Dr, Alhebaishi, Yahya, Alkhushail, Abdullah

    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: